The dappled dilemma facing vitiligo science
Elie Dolgin • Apr 05, 2019
Even as scientists celebrate progress in the lab, a stigma-busting movement asserts that those with the autoimmune skin condition are more in need of acceptance than medicine
Scientist John Harris doesn’t like to say the word “cure.” But after his discovery last year of a new strategy to alleviate a skin condition known as vitiligo, he now talks of a future in which long-term relief may be possible for the millions of people who have it.
Continue reading at Knowable Magazine.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.